Management of a critically ill patient with COVID-19-related fulminant myocarditis: A case report.
Respir Med Case Rep
; 36: 101611, 2022.
Article
in English
| MEDLINE | ID: covidwho-1692919
ABSTRACT
A 78-year-old man with COVID-19 infection was admitted. Initial echocardiography indicated left ventricular ejection fraction (LVEF) of 15%, high pulmonary arterial pressure, severe left ventricular dysfunction, mild diastolic dysfunction, mild regurgitation mitral valve, and normal septal thickness. Considering the probable diagnosis of COVID-19-related myocarditis, the patient was early managed with the antivirals, immunomodulatory agents, a high dose of ascorbic acid, melatonin, and immunoglobulin therapy. His clinical condition was improved and his last echocardiography revealed LVEF of 40% and improvement in systolic and diastolic dysfunction. The clinicians should be aware of the potentially lethal cardiac complication of COVID-19, especially in geriatrics.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Prognostic study
Language:
English
Journal:
Respir Med Case Rep
Year:
2022
Document Type:
Article
Affiliation country:
J.rmcr.2022.101611
Similar
MEDLINE
...
LILACS
LIS